New guidelines summarizing the available evidence about the diagnosis and workup of systemic amyloidosis, including transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), in tissue samples, as well as the challenges and limitations associated with common approaches and techniques, have been published.
For the full article click here: Guidelines Published for Diagnosing Amyloidosis